This bill proposes significant updates to the Arizona Revised Statutes concerning the Arizona State Board of Pharmacy. It introduces new notification requirements for permittees and licensees to inform the board within fifteen business days of any disciplinary actions taken against their permits or licenses in other jurisdictions, and mandates reporting of incidents involving adulterated or misbranded compounded medications that result in hospitalization or death. Additionally, it requires notification of unexpected closures lasting five days or more. The bill also specifies response times for producing requested documentation during investigations, clarifies definitions of various roles, and introduces new penalties for non-compliance with reporting requirements, while allowing for electronic notifications and extending deadlines for certain submissions. Moreover, the bill updates regulations regarding prescription drugs and controlled substances by requiring wholesalers and distributors to obtain a valid board-issued permit for distribution and removing references to "prescribing" and "consumption" in the tracking system for controlled substances. It mandates dispensers to report the date a prescription was sold to the ultimate user within one business day and eliminates the previous waiver provision for electronic reporting. The effective date for these changes is set for March 31, 2026. Overall, these updates aim to enhance regulatory oversight and streamline reporting processes for healthcare providers.

Statutes affected:
Introduced Version: 32-1901.01, 32-1904, 32-1923.01, 32-1925, 32-1926, 32-1926.01, 32-1927, 32-1927.01, 32-1927.02, 32-1930, 32-1941, 32-1965, 36-2602, 36-2604, 36-2606, 36-2608, 13-3451, 32-1963.01, 32-1936, 32-1937, 32-1968, 41-1831, 36-781, 36-661, 15-157, 36-2226.01, 15-344.01, 36-3601, 36-2228, 36-2266, 32-1994, 41-1758.03, 13-3401, 41-1061, 41-1091, 32-4301, 36-2501, 91-513, 36-2610, 12-2293, 23-1026, 11-593, 36-198, 36-2901, 11-594, 20-3151